Boehringer Ingelheim’s licensing agreement to use Owkin’s AI Scientist K Pro model and data network for oncology and immunology discovery demonstrates a sophisticated AI‑enabled partnership structure that procurement teams in pharma and other R&D‑heavy industries can mirror for strategic AI sourcing and long‑term data‑driven supplier collaboration.[15]
Loading…
